Sophie D. Fosså
Fosså, Sophie Dorothea 1941-
Fosså, Sophie D. 1941-
Fosså, Sophie D.
VIAF ID: 222970396 (Personal)
Permalink: http://viaf.org/viaf/222970396
Preferred Forms
-
100 1 _
‡a
Fosså, Sophie D.
-
100 1 _
‡a
Fosså, Sophie D.
‡d
1941-
-
100 1 _
‡a
Fosså, Sophie D.
‡d
1941-
-
100 1 _ ‡a Fosså, Sophie Dorothea ‡d 1941-
-
100 1 _ ‡a Fosså, Sophie Dorothea ‡d 1941-
-
100 0 _
‡a
Sophie D. Fosså
4xx's: Alternate Name Forms (9)
Works
| Title | Sources |
|---|---|
| Kreftoverlevere : ny kunnskap og nye muligheter i et langtidsperspektiv |
|
| Norske legers rutiner for opportunistisk screening for prostatakreft |
|
| Prostatakreft : en håndbok for pasienter og pårørende |
|
| Scanning absorption DNA cytophotometry in human bladder carcinoma |
|
| Serum testosterone level in patients with advanced prostatic cancer during androgen suppressive treatment |
|
| The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample |
|
| Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report |
|
| Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer |
|
| Short-term and long-term effect of prophylactic treatment of superficial bladder cancer with intravesical adriamycin. |
|
| Short-term and long-term elderly cancer survivors: A population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle |
|
| The significance of bone marrow acid phosphatase in patients with prostatic carcinoma |
|
| Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study |
|
| Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors |
|
| Somatic mutations of KIT in familial testicular germ cell tumours |
|
| Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. |
|
| Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy |
|
| Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment |
|
| [Spontaneous remission of metastases from renal cancer] |
|
| Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects |
|
| Stomach cancer risk after treatment for hodgkin lymphoma |
|
| Study of generic quality of life in patients operated on for post-prostatectomy incontinence |
|
| Survival after palliative radiotherapy of liver metastases. A search for prognostic factors |
|
| Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy. |
|
| T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values |
|
| Testicular cancer. A challenge to the health services taking care of young males |
|
| Testicular cancer in 2013: towards personalized medicine--are we there yet? |
|
| Testicular cancer survivorship: research strategies and recommendations |
|
| Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. |
|
| Testicular seminoma: analysis of treatment and failure for stage II disease |
|
| Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours. |
|
| Testikkelkreft : informasjon til pasienter, pårørende og andre interesserte |
|
| Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature |
|
| [Timely screening routines for prostatic cancer by Norwegian physicians] |
|
| Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy |
|
| To meet spiritual needs of the cancer patient--a responsibility for the oncologist? |
|
| Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. |
|
| Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. |
|
| Toxicity in long-term survivors after adriamycin containing chemotherapy of malignant germ-cell tumors |
|
| TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy |
|
| TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue |
|
| Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin |
|
| Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV |
|
| Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience |
|
| Treatment of advanced kidney adenocarcinoma |
|
| [Treatment of hormone-resistant prostate cancer] |
|
| Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation |
|
| [Treatment of muscle-infiltrating bladder cancer by preoperative irradiation and total cystectomy] |
|
| Treatment outcome of patients with brain metastases from malignant germ cell tumors |
|
| Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer |
|
| Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma |
|
| Trends in incidence of testicular cancer in Norway 1955-1992 |
|
| Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma |
|
| Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug |
|
| Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I |
|
| Urologic cancer in elderly patients |
|
| Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy |
|
| Utvidet registrering av prostatakreft i Norge |
|
| Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity |
|
| Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study |
|
| Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity |
|
| Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men |
|
| Viktig å vite om testikkelkreft |
|
| Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group |
|
| Vincristine in advanced bladder cancer: a European organization for research on treatment of cancer (EORTC) phase II study |
|
| Vindesine in advanced renal cancer. A study of the EORTC genito-urinary tract cancer cooperative group |
|
| Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study |
|
| Wernicke-Korsakoff-like syndrome in patients with colorectal carcinoma treated with high-dose doxifluridine (5'-dFUrd). |
|
| Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? |
|
| Work ability in prostate cancer survivors after radical prostatectomy |
|
| Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress. |
|
| Younger age-at-diagnosis for familial malignant testicular germ cell tumor |
|
